Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrium | 22 | 2023 | 403 | 6.740 |
Why?
|
Reproductive Medicine | 12 | 2021 | 99 | 5.870 |
Why?
|
Embryo Implantation | 19 | 2023 | 270 | 4.460 |
Why?
|
Preimplantation Diagnosis | 11 | 2021 | 143 | 4.330 |
Why?
|
Infertility | 11 | 2021 | 654 | 3.220 |
Why?
|
Preconception Care | 5 | 2019 | 141 | 2.820 |
Why?
|
Fertilization in Vitro | 12 | 2022 | 1292 | 2.430 |
Why?
|
Andrology | 3 | 2021 | 11 | 2.290 |
Why?
|
Blastocyst | 10 | 2023 | 433 | 2.190 |
Why?
|
Embryo Transfer | 8 | 2022 | 522 | 1.960 |
Why?
|
Reproduction | 5 | 2023 | 645 | 1.950 |
Why?
|
Reproductive Techniques, Assisted | 7 | 2022 | 497 | 1.880 |
Why?
|
Uterus | 6 | 2019 | 649 | 1.850 |
Why?
|
Infertility, Female | 7 | 2020 | 760 | 1.850 |
Why?
|
Aneuploidy | 7 | 2021 | 552 | 1.750 |
Why?
|
Gynatresia | 2 | 2023 | 11 | 1.590 |
Why?
|
Genetic Testing | 9 | 2021 | 3537 | 1.470 |
Why?
|
Endometritis | 3 | 2022 | 49 | 1.460 |
Why?
|
Decidua | 2 | 2021 | 82 | 1.430 |
Why?
|
Pregnancy | 42 | 2024 | 29890 | 1.160 |
Why?
|
Annexin A2 | 2 | 2019 | 44 | 1.080 |
Why?
|
Uterine Diseases | 2 | 2023 | 108 | 0.980 |
Why?
|
Hysteroscopy | 3 | 2020 | 62 | 0.910 |
Why?
|
Genetic Diseases, Inborn | 2 | 2019 | 604 | 0.900 |
Why?
|
Fertility | 5 | 2019 | 771 | 0.830 |
Why?
|
Myometrium | 2 | 2024 | 174 | 0.800 |
Why?
|
Anniversaries and Special Events | 2 | 2019 | 95 | 0.790 |
Why?
|
Vagina | 2 | 2018 | 838 | 0.780 |
Why?
|
Pre-Eclampsia | 2 | 2021 | 1231 | 0.740 |
Why?
|
Ectogenesis | 1 | 2019 | 8 | 0.680 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2022 | 1039 | 0.670 |
Why?
|
Dissent and Disputes | 1 | 2020 | 146 | 0.630 |
Why?
|
Bioengineering | 1 | 2019 | 99 | 0.620 |
Why?
|
Forecasting | 4 | 2021 | 2928 | 0.600 |
Why?
|
Genital Diseases, Female | 2 | 2019 | 192 | 0.590 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 583 | 0.570 |
Why?
|
Live Birth | 2 | 2022 | 511 | 0.570 |
Why?
|
Sperm Motility | 1 | 2018 | 266 | 0.550 |
Why?
|
Receptors, Progesterone | 1 | 2021 | 1129 | 0.550 |
Why?
|
Menstrual Cycle | 2 | 2017 | 539 | 0.550 |
Why?
|
Embryonic Development | 4 | 2023 | 721 | 0.540 |
Why?
|
Selection, Genetic | 1 | 2021 | 868 | 0.530 |
Why?
|
Cell Communication | 3 | 2023 | 1657 | 0.530 |
Why?
|
Genetic Counseling | 2 | 2017 | 627 | 0.520 |
Why?
|
Oocytes | 2 | 2018 | 1166 | 0.520 |
Why?
|
Pluripotent Stem Cells | 3 | 2013 | 799 | 0.520 |
Why?
|
Complementary Therapies | 1 | 2020 | 486 | 0.510 |
Why?
|
Reproductive History | 1 | 2017 | 211 | 0.510 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2021 | 0.490 |
Why?
|
Biological Evolution | 1 | 2021 | 1071 | 0.490 |
Why?
|
Erectile Dysfunction | 1 | 2018 | 444 | 0.470 |
Why?
|
Chromosome Disorders | 1 | 2017 | 497 | 0.460 |
Why?
|
Female | 57 | 2024 | 392705 | 0.450 |
Why?
|
Mosaicism | 1 | 2017 | 475 | 0.440 |
Why?
|
Totipotent Stem Cells | 1 | 2013 | 16 | 0.430 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1479 | 0.420 |
Why?
|
Diffusion of Innovation | 3 | 2021 | 728 | 0.400 |
Why?
|
Obstetrics | 1 | 2019 | 666 | 0.390 |
Why?
|
Embryonic Stem Cells | 4 | 2014 | 1263 | 0.390 |
Why?
|
History, 21st Century | 4 | 2021 | 1567 | 0.390 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1069 | 0.390 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 386 | 0.380 |
Why?
|
Humans | 73 | 2024 | 761596 | 0.380 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2012 | 234 | 0.370 |
Why?
|
Automation, Laboratory | 2 | 2021 | 102 | 0.370 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3688 | 0.360 |
Why?
|
Societies, Medical | 2 | 2019 | 3905 | 0.360 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1600 | 0.340 |
Why?
|
Actins | 2 | 2019 | 2050 | 0.340 |
Why?
|
Bacterial Infections | 1 | 2018 | 1391 | 0.340 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2451 | 0.330 |
Why?
|
Endometriosis | 2 | 2015 | 870 | 0.330 |
Why?
|
Stem Cells | 2 | 2019 | 3524 | 0.320 |
Why?
|
Bone Marrow | 1 | 2019 | 2911 | 0.310 |
Why?
|
Gene Expression Profiling | 7 | 2021 | 9420 | 0.310 |
Why?
|
Heterozygote | 1 | 2015 | 2787 | 0.310 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2947 | 0.310 |
Why?
|
Gardnerella vaginalis | 2 | 2018 | 20 | 0.290 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2578 | 0.290 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4111 | 0.280 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3639 | 0.270 |
Why?
|
Research Design | 1 | 2022 | 6180 | 0.270 |
Why?
|
Spain | 4 | 2021 | 487 | 0.270 |
Why?
|
Policy Making | 2 | 2021 | 542 | 0.270 |
Why?
|
Ovulation Induction | 3 | 2022 | 277 | 0.260 |
Why?
|
Spermatozoa | 4 | 2021 | 630 | 0.260 |
Why?
|
Lactobacillus | 2 | 2018 | 212 | 0.260 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3889 | 0.260 |
Why?
|
Biopsy | 5 | 2021 | 6766 | 0.250 |
Why?
|
Leiomyoma | 2 | 2022 | 636 | 0.250 |
Why?
|
Cell Differentiation | 6 | 2015 | 11530 | 0.240 |
Why?
|
Germ Cells | 3 | 2014 | 634 | 0.230 |
Why?
|
Cell Culture Techniques | 2 | 2016 | 1668 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.190 |
Why?
|
Models, Biological | 2 | 2015 | 9469 | 0.180 |
Why?
|
Culture Media | 2 | 2021 | 897 | 0.180 |
Why?
|
Fertilization | 1 | 2022 | 199 | 0.180 |
Why?
|
Genetic Code | 1 | 2021 | 138 | 0.180 |
Why?
|
Labor, Obstetric | 1 | 2024 | 323 | 0.180 |
Why?
|
Genome, Human | 1 | 2013 | 4425 | 0.170 |
Why?
|
Fibroblasts | 1 | 2010 | 4142 | 0.160 |
Why?
|
Placentation | 1 | 2019 | 78 | 0.160 |
Why?
|
Paternal Age | 1 | 2019 | 87 | 0.160 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2019 | 127 | 0.160 |
Why?
|
Exosomes | 1 | 2023 | 424 | 0.160 |
Why?
|
Quarantine | 1 | 2021 | 181 | 0.160 |
Why?
|
Perinatal Mortality | 1 | 2019 | 101 | 0.160 |
Why?
|
Mycoplasma hominis | 1 | 2018 | 10 | 0.150 |
Why?
|
Signal Transduction | 1 | 2021 | 23447 | 0.150 |
Why?
|
Embryo, Mammalian | 2 | 2023 | 1674 | 0.150 |
Why?
|
Trisomy | 1 | 2019 | 260 | 0.150 |
Why?
|
Trophoblasts | 1 | 2019 | 224 | 0.150 |
Why?
|
Fathers | 1 | 2021 | 376 | 0.150 |
Why?
|
Leiomyosarcoma | 1 | 2022 | 422 | 0.150 |
Why?
|
Mycoplasma Infections | 1 | 2018 | 120 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 588 | 0.150 |
Why?
|
Staphylococcus | 1 | 2018 | 154 | 0.150 |
Why?
|
Prolactin | 1 | 2019 | 625 | 0.140 |
Why?
|
Streptococcus | 1 | 2018 | 198 | 0.140 |
Why?
|
Ovary | 1 | 2022 | 959 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 17904 | 0.140 |
Why?
|
Cicatrix | 1 | 2023 | 798 | 0.140 |
Why?
|
Culture Techniques | 1 | 2018 | 531 | 0.140 |
Why?
|
Pregnancy Rate | 2 | 2019 | 648 | 0.140 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15266 | 0.140 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3430 | 0.140 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 131 | 0.140 |
Why?
|
Enterococcus | 1 | 2018 | 159 | 0.140 |
Why?
|
Cell Line | 2 | 2010 | 15601 | 0.140 |
Why?
|
Prevotella | 1 | 2016 | 80 | 0.140 |
Why?
|
Treatment Refusal | 1 | 2020 | 429 | 0.140 |
Why?
|
Spermatogonia | 1 | 2016 | 30 | 0.140 |
Why?
|
Klebsiella Infections | 1 | 2018 | 146 | 0.140 |
Why?
|
Estrogens | 1 | 2003 | 1522 | 0.130 |
Why?
|
Chlamydia trachomatis | 1 | 2018 | 239 | 0.130 |
Why?
|
Central Nervous System Cysts | 1 | 2016 | 56 | 0.130 |
Why?
|
Klebsiella pneumoniae | 1 | 2018 | 250 | 0.130 |
Why?
|
Bacterial Typing Techniques | 1 | 2016 | 263 | 0.130 |
Why?
|
Male | 18 | 2021 | 360846 | 0.130 |
Why?
|
Telomere-Binding Proteins | 1 | 2016 | 119 | 0.130 |
Why?
|
Chronic Disease | 3 | 2022 | 9319 | 0.130 |
Why?
|
Withholding Treatment | 1 | 2020 | 617 | 0.130 |
Why?
|
Muscle Spasticity | 1 | 2016 | 156 | 0.120 |
Why?
|
Neisseria gonorrhoeae | 1 | 2018 | 239 | 0.120 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2018 | 343 | 0.120 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1380 | 0.120 |
Why?
|
Pathology, Molecular | 1 | 2018 | 328 | 0.120 |
Why?
|
Cells, Cultured | 5 | 2019 | 18966 | 0.120 |
Why?
|
Chlamydia Infections | 1 | 2018 | 365 | 0.120 |
Why?
|
Plasma Cells | 1 | 2018 | 599 | 0.120 |
Why?
|
Government Regulation | 1 | 2019 | 524 | 0.120 |
Why?
|
Stromal Cells | 1 | 2019 | 1330 | 0.110 |
Why?
|
Ataxia | 1 | 2016 | 306 | 0.110 |
Why?
|
Luteinizing Hormone | 1 | 2016 | 820 | 0.110 |
Why?
|
Infant Mortality | 1 | 2019 | 759 | 0.110 |
Why?
|
Escherichia coli Infections | 1 | 2018 | 518 | 0.110 |
Why?
|
Registries | 1 | 2010 | 8225 | 0.110 |
Why?
|
Gonorrhea | 1 | 2018 | 346 | 0.110 |
Why?
|
Blastocyst Inner Cell Mass | 1 | 2013 | 7 | 0.110 |
Why?
|
Placenta | 1 | 2023 | 1709 | 0.110 |
Why?
|
Infant, Newborn, Diseases | 1 | 2019 | 589 | 0.110 |
Why?
|
Blastomeres | 1 | 2013 | 29 | 0.110 |
Why?
|
Streptococcal Infections | 1 | 2018 | 617 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2016 | 945 | 0.110 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 256 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2015 | 3612 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1420 | 0.110 |
Why?
|
Species Specificity | 1 | 2017 | 2414 | 0.100 |
Why?
|
Proprotein Convertase 5 | 1 | 2012 | 3 | 0.100 |
Why?
|
Pilot Projects | 2 | 2016 | 8633 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2015 | 750 | 0.100 |
Why?
|
Infant, Newborn | 3 | 2023 | 26202 | 0.100 |
Why?
|
Abortion, Spontaneous | 3 | 2019 | 533 | 0.100 |
Why?
|
Models, Animal | 1 | 2018 | 2112 | 0.100 |
Why?
|
Integrin alpha Chains | 1 | 2012 | 95 | 0.100 |
Why?
|
Animals | 12 | 2023 | 168475 | 0.100 |
Why?
|
DEAD-box RNA Helicases | 2 | 2012 | 384 | 0.100 |
Why?
|
Life Change Events | 1 | 2017 | 952 | 0.100 |
Why?
|
DNA, Complementary | 1 | 2015 | 1991 | 0.100 |
Why?
|
Tissue Donors | 1 | 2021 | 2332 | 0.090 |
Why?
|
Consensus | 1 | 2021 | 3124 | 0.090 |
Why?
|
Genome, Bacterial | 1 | 2016 | 783 | 0.090 |
Why?
|
Bibliometrics | 1 | 2015 | 352 | 0.090 |
Why?
|
Prenatal Care | 1 | 2019 | 1141 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2021 | 1220 | 0.090 |
Why?
|
Treatment Failure | 1 | 2017 | 2643 | 0.090 |
Why?
|
Thalidomide | 1 | 2016 | 885 | 0.090 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 522 | 0.090 |
Why?
|
Ergolines | 1 | 2010 | 57 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2014 | 1860 | 0.090 |
Why?
|
Pregnancy Outcome | 2 | 2022 | 2922 | 0.090 |
Why?
|
Retinal Diseases | 1 | 2016 | 705 | 0.090 |
Why?
|
Attitude to Health | 1 | 2019 | 2025 | 0.090 |
Why?
|
Cell Proliferation | 2 | 2016 | 10451 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 943 | 0.090 |
Why?
|
Meiosis | 1 | 2012 | 328 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2020 | 64685 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1123 | 0.080 |
Why?
|
Internationality | 1 | 2015 | 1001 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4740 | 0.080 |
Why?
|
Staphylococcal Infections | 1 | 2018 | 1407 | 0.080 |
Why?
|
Mice | 7 | 2023 | 81539 | 0.080 |
Why?
|
Risk Factors | 5 | 2019 | 74213 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3575 | 0.080 |
Why?
|
DNA Methylation | 2 | 2021 | 4399 | 0.080 |
Why?
|
Gene Regulatory Networks | 2 | 2016 | 1745 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1505 | 0.070 |
Why?
|
DNA Primers | 1 | 2012 | 2820 | 0.070 |
Why?
|
Ligands | 1 | 2014 | 3272 | 0.070 |
Why?
|
Receptors, Dopamine D2 | 1 | 2010 | 485 | 0.070 |
Why?
|
Dopamine Agonists | 1 | 2010 | 352 | 0.070 |
Why?
|
Calcinosis | 1 | 2016 | 1469 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1171 | 0.070 |
Why?
|
Cell Movement | 1 | 2019 | 5205 | 0.070 |
Why?
|
Young Adult | 4 | 2021 | 59260 | 0.070 |
Why?
|
Risk Assessment | 2 | 2019 | 23996 | 0.070 |
Why?
|
Prospective Studies | 5 | 2022 | 54423 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6075 | 0.070 |
Why?
|
Myoma | 1 | 2006 | 6 | 0.070 |
Why?
|
Comparative Genomic Hybridization | 2 | 2020 | 473 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3779 | 0.070 |
Why?
|
RNA-Binding Proteins | 2 | 2012 | 1898 | 0.060 |
Why?
|
MicroRNAs | 2 | 2019 | 3816 | 0.060 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11904 | 0.060 |
Why?
|
Mullerian Ducts | 1 | 2006 | 203 | 0.060 |
Why?
|
Escherichia coli | 1 | 2018 | 4217 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2822 | 0.060 |
Why?
|
Regenerative Medicine | 1 | 2009 | 306 | 0.060 |
Why?
|
Oocyte Donation | 2 | 2019 | 52 | 0.060 |
Why?
|
Adult | 7 | 2021 | 221210 | 0.060 |
Why?
|
DNA, Mitochondrial | 2 | 2023 | 865 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8466 | 0.060 |
Why?
|
Phenotype | 3 | 2016 | 16592 | 0.060 |
Why?
|
Mutation | 3 | 2021 | 30053 | 0.050 |
Why?
|
Oxidants | 1 | 2004 | 169 | 0.050 |
Why?
|
International Cooperation | 1 | 2010 | 1422 | 0.050 |
Why?
|
Seizures | 1 | 2016 | 2957 | 0.050 |
Why?
|
Up-Regulation | 1 | 2012 | 4125 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12059 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18255 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14665 | 0.050 |
Why?
|
Genetic Markers | 2 | 2021 | 2601 | 0.050 |
Why?
|
Aging | 2 | 2024 | 8710 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2016 | 22176 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13255 | 0.050 |
Why?
|
Synaptonemal Complex | 2 | 2012 | 24 | 0.050 |
Why?
|
Semen | 1 | 2004 | 347 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.050 |
Why?
|
Genomics | 1 | 2016 | 5821 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2024 | 926 | 0.040 |
Why?
|
Anti-Mullerian Hormone | 1 | 2022 | 407 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Coculture Techniques | 2 | 2014 | 1341 | 0.040 |
Why?
|
Biomass | 1 | 2019 | 137 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10774 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2024 | 1201 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12953 | 0.040 |
Why?
|
Genitalia, Female | 1 | 2019 | 147 | 0.040 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2019 | 156 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1303 | 0.040 |
Why?
|
Semen Analysis | 1 | 2019 | 236 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20100 | 0.040 |
Why?
|
Endometrial Neoplasms | 1 | 2006 | 1366 | 0.030 |
Why?
|
Chromosomes | 1 | 2020 | 578 | 0.030 |
Why?
|
Infant | 1 | 2019 | 36193 | 0.030 |
Why?
|
Prognosis | 1 | 2017 | 29629 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11076 | 0.030 |
Why?
|
Antioxidants | 1 | 2004 | 1668 | 0.030 |
Why?
|
Texas | 1 | 2016 | 404 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9032 | 0.030 |
Why?
|
Oocyte Retrieval | 1 | 2016 | 160 | 0.030 |
Why?
|
Child | 1 | 2023 | 80158 | 0.030 |
Why?
|
United States | 2 | 2019 | 72340 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 532 | 0.030 |
Why?
|
Embryo Culture Techniques | 1 | 2014 | 84 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12947 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 2014 | 178 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 2014 | 258 | 0.030 |
Why?
|
Receptors, Growth Factor | 1 | 2014 | 326 | 0.030 |
Why?
|
Journal Impact Factor | 1 | 2015 | 153 | 0.030 |
Why?
|
Expert Testimony | 1 | 2016 | 364 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1768 | 0.030 |
Why?
|
Ovum | 1 | 2014 | 187 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 2012 | 3733 | 0.030 |
Why?
|
Growth Substances | 1 | 2014 | 768 | 0.030 |
Why?
|
California | 1 | 2016 | 1430 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 21355 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1328 | 0.020 |
Why?
|
Hormones | 1 | 2014 | 869 | 0.020 |
Why?
|
Haploidy | 1 | 2010 | 126 | 0.020 |
Why?
|
History, 20th Century | 1 | 2018 | 2767 | 0.020 |
Why?
|
Molecular Biology | 1 | 2014 | 576 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1112 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 909 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2010 | 748 | 0.020 |
Why?
|
Fibronectins | 1 | 2012 | 723 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 459 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1403 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1529 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 546 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 220921 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3801 | 0.020 |
Why?
|
Adolescent | 2 | 2012 | 88326 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12973 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 80647 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2065 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5791 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2012 | 3088 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 842 | 0.020 |
Why?
|
Zebrafish | 1 | 2016 | 3008 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2016 | 2882 | 0.010 |
Why?
|
Glycoproteins | 1 | 2012 | 2203 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1974 | 0.010 |
Why?
|
Life Style | 1 | 2016 | 3917 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 39969 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3614 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3624 | 0.010 |
Why?
|
Infertility, Male | 1 | 2004 | 395 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2016 | 4481 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7396 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5722 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18399 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2010 | 2811 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10766 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2139 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2004 | 3113 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15843 | 0.010 |
Why?
|
Concepts
(329)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_